表紙
市場調查報告書
商品編碼
1074646

全球藥品合同製造市場分析2022-2032:按服務(藥品製造,藥物開發,生物製藥合同製造)預測,用戶預測,地區/主要國家分析,主要公司,COVID-19復甦情景

Pharmaceutical Contract Manufacturing Market Report 2022-2032: Forecasts by Services - Pharmaceutical Manufacturing, Drug Development, Biologics Contract Manufacturing, End-user, Leading National Market Analysis & Companies, COVID-19 Recovery Scenarios

出版日期: | 出版商: Visiongain Reports Ltd. | 英文 441 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

到 2022 年,全球藥品合同製造市場預計將超過 1260 億美元。預計它還將繼續擴大到 2032 年。

幾十年來,世界各地的 CDMO(合同製造組織)穩步建立了與藥品全面製造相關的專有技術和設備。大公司正計劃向尋求技術開發、加工和生產服務的公司提供 CDMO 服務。

本報告分析了全球藥品合同製造市場,並概述了服務、市場的基本結構/最新情況、主要促進/制約因素以及估計/預測的市場規模(2022-2032年)、按服務/最終用戶和地區/主要國家/地區劃分的詳細趨勢、主要公司概況、COVID-19 的影響和恢復情況等。

圖表示例

目錄

第1章分析概述

第2章執行摘要

第 3 章全球藥品合同製造市場:定性分析

  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會
  • SWOT分析
  • PEST 分析
  • 波特五力分析
  • 新型冠狀病毒感染(COVID-19)的影響分析
    • V型複蘇
    • U型複蘇
    • L 型複蘇
    • W型複蘇

第 4 章全球藥品合同製造市場:按服務 (2022-2032)

  • 市場預測:按服務分類 (2022-2032)
  • 醫藥製造服務
    • 市場預測:按地區劃分(2022-2032 年)
    • COVID-19 的影響:復甦情景(V 型/U 型/W 型/L 型)
    • 醫藥原料藥(原料藥)製造服務
    • 醫藥FDF(最終配方)製造服務
  • 藥物研發服務
  • 生物製藥合同製造服務
    • Bioform API 製造服務
    • 生物製藥 FDF 製造服務

第 5 章全球藥品合同製造市場:按最終用戶 (2022-2032)

  • 市場預測:按最終用戶分類 (2022-2032)
  • 一家大型製藥公司
  • 中小型製藥公司
  • 仿製藥公司
  • 其他最終用戶

第 6 章北美合同製造市場 (2022-2032)

  • COVID-19 的影響:復甦情景(V 型/U 型/W 型/L 型)
  • 市場預測:按服務分類 (2022-2032)
    • 醫藥製造服務
    • 生物製藥製造服務
  • 市場預測:按最終用戶分類 (2022-2032)
  • 市場預測:按國家分類(2022-2032 年)
  • 美國
  • 加拿大

第 7 章歐洲合同製造市場 (2022-2032)

  • COVID-19 的影響:復甦情景(V 型/U 型/W 型/L 型)
  • 市場預測:按服務分類 (2022-2032)
  • 市場預測:按最終用戶分類 (2022-2032)
  • 市場預測:按國家分類(2022-2032 年)
  • 德國
  • 英國
  • 瑞士
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲國家

第 8 章亞太藥品合同製造市場 (2022-2032)

  • COVID-19 的影響:復甦情景(V 型/U 型/W 型/L 型)
  • 市場預測:按服務分類 (2022-2032)
  • 市場預測:按最終用戶分類 (2022-2032)
  • 市場預測:按國家分類(2022-2032 年)
  • 日本
  • 中國
  • 印度
  • 韓國
  • 其他亞太國家

第 9 章拉丁美洲/中東/非洲(LAMEA)藥品合同製造市場(2022-2032)

  • COVID-19 的影響:復甦情景(V 型/U 型/W 型/L 型)
  • 市場預測:按服務分類 (2022-2032)
  • 市場預測:按最終用戶分類 (2022-2032)
  • 市場預測:按國家分類(2022-2032 年)
  • 巴西
  • 墨西哥
  • 沙特阿拉伯
  • 其他 LAMEA 國家

第 10 章公司簡介

  • 市場份額分析
  • LONZA GROUP
    • 公司簡介
    • 公司快照
    • 服務組合
    • 財務分析
    • 近期趨勢
  • THERMO FISHER SCIENTIFIC INC.
  • CATALENT
  • RECIPHARM AB
  • ABBVIE
  • SIEGFRIED HOLDING AG
  • EVONIK INDUSTRIES
  • BOEHRINGER INGELHEIM
  • PIRAMAL PHARMA SOLUTIONS
  • SAMSUNG BIOLOGICS
  • WUXI APPTEC (WUXI STA)
  • FUJIFILM HEALTHCARE
  • ICON PLC
  • ABNOVA CORPORATION
  • VETTER PHARMA INTERNATIONAL

第11章 結論及建議

目錄
Product Code: PHA1157

Title:
Pharmaceutical Contract Manufacturing Market Report 2022-2032
Forecasts by Services (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Drug Development Services, Biologics Contract Manufacturing Services (Biologics API Manufacturing Services, Biologics FDF Manufacturing Services)), by End-user (Big Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

Investments in Advanced Manufacturing Technologies by CDMOs

In the last few decades, CDMOs have steadily established expertise and facilities to manufacture drugs at full scale. They have incorporated various methods for manufacturing drugs at the lowest possible operational cost. An increasing number of contract manufacturers are investing in continuous manufacturing methods as well to conventions in batch processing methods. Due to the availability of advanced technology, the major companies are planning to provide CDMO services for companies seeking technology development, processing and production services.

Also, to spur growth, the CDMO industry is taking on capital projects and investing in new technologies to share risks with manufacturers, in response to the high capacity utilization rates. As indicated by the higher utilization rates, they are also hiring more personnel. The manufacturing of highly potent active pharmaceutical ingredients (HPAPIs) requires complex manufacturing processes; advanced synthesis and formulation expertise; and special protective equipment, manufacturing sites, production processes, and management systems. Such strategic expansions, investments, and acquisitions by CDMOs have helped them increase their service offerings and expand their customer base while providing significant cross-selling opportunities.

Services Analysis

Drug development services, pharmaceutical manufacturing services, and biologic manufacturing services are all subcategories of the pharmaceutical contract manufacturing sector. Pharmaceutical manufacturers' limited financial resources, capacity constraints, the need to shorten time-to-market, complex manufacturing requirements, large investments in setting up manufacturing facilities, and the expanding pipeline have all contributed to this market segment's dominance of pharmaceutical contract manufacturing.

Large portions of this market can be attributed to the fact that pharmaceutical manufacturers have limited resources and therefore must turn to Pharmaceutical Contract manufacturing in order to cut down on time-to-market and meet the increasingly complex manufacturing needs that have resulted from the high costs of setting up manufacturing facilities as well as the ever-expanding pipeline. On the other hand, the biologics manufacturing segment is expected to grow at the highest rate owing to the growing demand for vaccines and biosimilars.

What are the Growth Drivers for Pharmaceutical Contract Manufacturing Market?

  • Patent expiry and increasing demand for generic drugs
  • Increasing investments in pharmaceutical R&D
  • Investments In advanced manufacturing technologies by CDMOs

What are the Market Opportunities?

  • Increasing demand for biological therapies
  • Growth in the nuclear medicine sector
  • Growing demand for cell and gene therapies

Discover how to stay ahead

Our 440+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter's Five Forces, SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets

By Services

  • Pharmaceutical Manufacturing Services
    • Pharmaceutical API Manufacturing Services
    • Pharmaceutical FDF Manufacturing Services
  • Drug Development Services
  • Biologics contract manufacturing services
    • Biologics API manufacturing services
    • Biologics FDF manufacturing services

By End User

  • Big Pharmaceutical Companies
  • Small & Medium-Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 14 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Mexico
    • Rest of LAMEA

Leading companies and the potential for market growth

Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $126 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market- including company profiles for 18 of the major companies involved in the Pharmaceutical Contract Manufacturing market. Some of the companies profiled in this report include AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.

How the Pharmaceutical Contract Manufacturing Market report helps you

In summary, our 440+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Pharmaceutical Contract Manufacturing Market, with forecasts for 3 services, and 4 end-users each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2032 for 4 regional and 14 key national markets- See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 15 of the companies involved in the Pharmaceutical Contract Manufacturing Market.

Some of the company's profiled in this report include: AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pharmaceutical Contract Manufacturing Market and leading companies. You will find data, trends, and predictions.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Introduction to Global Pharmaceutical Contract Manufacturing Market
  • 1.2 Global Pharmaceutical Contract Manufacturing Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Primary Research
    • 1.7.2 Secondary Research
    • 1.7.3 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Qualitative Analysis of the Global Pharmaceutical Contract Manufacturing Market

  • 3.1 Market Dynamics
    • 3.1.1 Drivers
      • 3.1.1.1 Patent expiry and increasing demand for generic drugs
      • 3.1.1.2 Increasing investments in pharmaceutical R&D
      • 3.1.1.3 Investments in advanced manufacturing technologies by CDMOs
    • 3.1.2 Restraints
      • 3.1.2.1 Introduction of serialization
    • 3.1.3 OPPORTUNITIES
      • 3.1.3.1 Increasing demand for biological therapies
      • 3.1.3.2 Growth in the nuclear medicine sector
      • 3.1.3.3 Growing demand for cell and gene therapies
  • 3.2 SWOT Analysis
  • 3.3 PEST Analysis
    • 3.3.1 Political
    • 3.3.2 Economic
    • 3.3.3 Sociocultural
    • 3.3.4 Technological
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Moderate Bargaining Power of Supplier
    • 3.4.2 High Bargaining Power of Buyer
    • 3.4.3 Low Threat of New Entrants
    • 3.4.4 Low Threat of Substitutes
    • 3.4.5 High Intensity of Competitive Rivalry
  • 3.5 COVID-19 Impact Analysis
    • 3.5.1 V-Shaped Recovery
    • 3.5.2 U-Shaped Recovery
    • 3.5.3 L-Shaped Recovery
    • 3.5.4 W-Shaped Recovery

4 Global Pharmaceutical Contract Manufacturing Market, by Services, 2022-2032

  • 4.1 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032
  • 4.2 PHARMACEUTICAL MANUFACTURING SERVICES
    • 4.2.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services by Region: Market Forecast, 2022-2032
    • 4.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
    • 4.2.3 PHARMACEUTICAL API MANUFACTURING SERVICES
      • 4.2.3.1 Need to cut costs and ensure focus on core areas leads companies to outsource API manufacturing
      • 4.2.3.2 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services by Region: Market Forecast, 2022-2032
      • 4.2.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services: Recovery Scenarios (V, U, W, L)
    • 4.2.4 PHARMACEUTICAL FDF MANUFACTURING SERVICES
      • 4.2.4.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services by Region: Market Forecast, 2022-2032
      • 4.2.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services: Recovery Scenarios (V, U, W, L)
      • 4.2.4.3 Parenteral/Injectable manufacturing services
        • 4.2.4.3.1 Need for high levels of expertise and growing drug development activities are driving the demand for contract manufacturing
        • 4.2.4.3.2 Global Pharmaceutical Contract Manufacturing Market for Parenteral/injectable manufacturing services: Market Forecast, 2022-2032
      • 4.2.4.4 Tablet manufacturing services
        • 4.2.4.4.1 Shifting manufacturing requirements and the need to streamline production processes are driving market growth
        • 4.2.4.4.2 Global Pharmaceutical Contract Manufacturing Market for Tablet manufacturing services: Market Forecast, 2022-2032
      • 4.2.4.5 Capsule manufacturing services
        • 4.2.4.5.1 Growth in demand for capsule formulations has ensured growth opportunities for service providers
        • 4.2.4.5.2 Global Pharmaceutical Contract Manufacturing Market for Capsule manufacturing services: Market Forecast, 2022-2032
      • 4.2.4.6 Oral liquid manufacturing services
        • 4.2.4.6.1 Complexities involved in oral liquid manufacturing have prompted companies to opt for outsourcing
        • 4.2.4.6.2 Global Pharmaceutical Contract Manufacturing Market for Oral liquid manufacturing services: Market Forecast, 2022-2032
      • 4.2.4.7 Semi-solid manufacturing services
        • 4.2.4.7.1 Demand for specific manufacturing facilities to boost the outsourcing of semi -solids
        • 4.2.4.7.2 Global Pharmaceutical Contract Manufacturing Market for Semi-solid manufacturing services: Market Forecast, 2022-2032
      • 4.2.4.8 Other Formulation manufacturing services
        • 4.2.4.8.1 Demand for specific manufacturing facilities to boost the outsourcing of semi -solids
        • 4.2.4.8.2 Global Pharmaceutical Contract Manufacturing Market for Other Formulation manufacturing services: Market Forecast, 2022-2032
  • 4.3 Drug Development Services
    • 4.3.1 Drug Substance Complexity And High Costs Have Supported The Outsourcing Of Drug Development
    • 4.3.2 Global Pharmaceutical Contract Manufacturing Market for Drug Development Services: Market Forecast, 2022-2032
    • 4.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services: Recovery Scenarios (V, U, W, L)
  • 4.4 Biologics Contract Manufacturing Services
    • 4.4.1 Global Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services: Market Forecast, 2022-2032
    • 4.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services: Recovery Scenarios (V, U, W, L)
    • 4.4.1 Biologics API Manufacturing Services
      • 4.4.1.1 This market is still in the nascent phase
      • 4.4.1.2 Global Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services by Region: Market Forecast, 2022-2032
      • 4.4.1.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
    • 4.4.2 Biologics FDF Manufacture Service
      • 4.4.2.1 Increasing R&D costs and process complexity have prompted the shift toward contract manufacturing
      • 4.4.2.2 Global Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service by Region: Market Forecast, 2022-2032
      • 4.4.2.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service: Recovery Scenarios (V, U, W, L)

5 Global Pharmaceutical Contract Manufacturing Market, by End User, 2022-2032

  • 5.1 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032
  • 5.2 Big Pharmaceutical Companies
    • 5.2.1 Global Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies by Region: Market Forecast, 2022-2032
    • 5.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Big pharmaceutical companies: Recovery Scenarios (V, U, W, L)
  • 5.3 Small & Medium-Sized Pharmaceutical Companies
    • 5.3.1 Growing Development Of Biologic Drugs And High Pricing Pressure To Boost Market Growth
    • 5.3.2 Global Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies by Region: Market Forecast, 2022-2032
    • 5.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
  • 5.4 Generic Pharmaceutical Companies
    • 5.4.1 Growing Demand For Generics To Support Market Growth
    • 5.4.2 Global Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies by Region: Market Forecast, 2022-2032
    • 5.4.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
  • 5.5 Other End Users
    • 5.5.1 Global Pharmaceutical Contract Manufacturing Market for Other End Users by Region: Market Forecast, 2022-2032
    • 5.5.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Other End Users: Recovery Scenarios (V, U, W, L)

6 North America Pharmaceutical Contract Manufacturing Market, 2022-2032

  • 6.1.1 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 6.2 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 6.2.1 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 6.2.2 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032
  • 6.3 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
  • 6.4 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
  • 6.5 US
    • 6.5.1 The US dominates the North American Pharmaceutical Contract manufacturing market
    • 6.5.2 Increasing funding from Federal Government
    • 6.5.3 U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 6.5.4 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 6.5.5 US Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 6.5.6 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 6.5.7 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 6.6 Canada
    • 6.6.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth
    • 6.6.2 Government initiatives to promote pharmaceutical contract manufacturing in various indications to drive market growth in Canada
    • 6.6.3 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 6.6.4 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 6.6.5 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 6.6.6 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 6.6.7 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

7 Europe Pharmaceutical Contract Manufacturing Market, 2022-2032

  • 7.1.1 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.2 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.2.1 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.2.2 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
  • 7.3 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
  • 7.4 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
  • 7.5 Germany
    • 7.5.1 High healthcare expenditure by the country
    • 7.5.2 Increased pharmaceutical production to support market demand
    • 7.5.3 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.5.4 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.5.5 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.5.6 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.5.7 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.6 UK
    • 7.6.1 Growth In The Generics Market And The Rising Cost Of Manufacturing Parenteral Formulations Are Driving Market Growth
    • 7.6.2 Increasing R&D research will boost the market
    • 7.6.3 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.6.4 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.6.5 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.6.6 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.6.7 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.7 Switzerland
    • 7.7.1 Large volume of pharmaceutical production and growing scope for generics to provide growth opportunities
    • 7.7.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth.
    • 7.7.3 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.7.4 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.7.5 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.7.6 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.7.7 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.8 France
    • 7.8.1 Presence of leading pharmaceutical companies to support market growth in France
    • 7.8.2 Availability of reimbursement
    • 7.8.3 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.8.4 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.8.5 France Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.8.6 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.8.7 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.9 Italy
    • 7.9.1 Increasing focus on clinical research and the growing popularity of branded drugs are driving the demand for contract development and manufacturing
    • 7.9.2 Economic slowdown of Italian healthcare industry
    • 7.9.3 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.9.4 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.9.5 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.9.6 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.9.7 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.10 Spain
    • 7.10.1 Increase in biologics production to support market growth
    • 7.10.2 Advancement in the production and research of innovative drugs
    • 7.10.3 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.10.4 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.10.5 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.10.6 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.10.7 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 7.11 Rest of Europe
    • 7.11.1 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 7.11.2 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 7.11.3 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 7.11.4 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 7.11.5 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

8 Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2022-2032

  • 8.1.1 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 8.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.2.1 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.2.2 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032
  • 8.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
  • 8.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
  • 8.5 Japan
    • 8.5.1 Growing generics demand to drive the demand for contract manufacturing of drugs
    • 8.5.2 Government initiatives to increase the use of generic drugs
    • 8.5.3 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.5.4 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.5.5 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 8.5.6 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 8.5.7 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 8.6 China
    • 8.6.1 Favourable government regulations are fuelling market growth in China
    • 8.6.2 Strong focus of key market players to expand their business In China
    • 8.6.3 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.6.4 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.6.5 China Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 8.6.6 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 8.6.7 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 8.7 India
    • 8.7.1 Low manufacturing costs is attracting outsourcing
    • 8.7.2 Presence of skilled workforce
    • 8.7.3 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.7.4 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.7.5 India Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 8.7.6 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 8.7.7 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 8.8 South Korea
    • 8.8.1 Government investments are a key contributor to market growth in South Korea
    • 8.8.2 Increase in initiative of government research funding
    • 8.8.3 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.8.4 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.8.5 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 8.8.6 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 8.8.7 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 8.9 Rest of APAC
    • 8.9.1 Singapore and Malaysia are major markets in Rest of APAC
    • 8.9.2 Taiwan and Malaysia are some of the emerging countries
    • 8.9.3 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 8.9.4 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 8.9.5 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 8.9.6 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 8.9.7 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

9 Latin America, Middle East & Africa (LAMEA) Pharmaceutical Contract Manufacturing Market, 2022-2032

  • 9.1.1 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 9.2 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 9.2.1 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 9.2.2 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
  • 9.3 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
  • 9.4 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
  • 9.5 Brazil
    • 9.5.1 Increasing focus of BNCs on the pharmaceutical and healthcare sectors
    • 9.5.2 Production-development partnerships have been implemented
    • 9.5.3 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 9.5.4 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 9.5.5 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 9.5.6 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 9.5.7 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 9.6 Mexico
    • 9.6.1 One of the largest exporters of pharmaceutical products in Latin America
    • 9.6.2 Increased focus among key players to expand their business in Mexico
    • 9.6.3 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 9.6.4 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 9.6.5 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 9.6.6 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 9.6.7 Mexico
    • 9.6.8 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 9.7 Saudi Arabia
    • 9.7.1 Largest pharmaceutical market in the Middle East
    • 9.7.2 High-profile agreements and collaborations in the country
    • 9.7.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 9.7.4 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 9.7.5 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 9.7.6 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 9.7.7 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
  • 9.8 Rest of LAMEA
    • 9.8.1 Government initiatives to tackle the growing burden of pharmaceutical costs
    • 9.8.2 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
    • 9.8.3 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
    • 9.8.4 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
    • 9.8.5 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
    • 9.8.6 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

10 Company Profiles

  • 10.1 Market Share Analysis
  • 10.2 LONZA GROUP
    • 10.2.1 Company overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Service Portfolio
    • 10.2.4 Financial Analysis
      • 10.2.4.1 Net Revenue, 2016-2020
      • 10.2.4.2 Segmental Revenue Shares, 2020
      • 10.2.4.3 Regional Revenue Shares, 2020
    • 10.2.5 Recent Developments, 2017-2020
  • 10.3 THERMO FISHER SCIENTIFIC INC.
    • 10.3.1 Company overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Service Portfolio
    • 10.3.4 Financial Analysis Net Revenue, 2016-2020
      • 10.3.4.1 Segmental Revenue Shares, 2020
      • 10.3.4.2 Regional Revenue Shares, 2020
    • 10.3.5 Recent Developments, 2018-2020
  • 10.4 CATALENT
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Service Portfolio
    • 10.4.4 Financial Analysis
      • 10.4.4.1 Net Revenue, 2016-2020
      • 10.4.4.2 Segmental Revenue Shares, 2021
      • 10.4.4.3 Regional Revenue Shares, 2021
    • 10.4.5 Recent Developments, 2018-2020
  • 10.5 RECIPHARM AB
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Service Portfolio
    • 10.5.4 Financial Analysis
      • 10.5.4.1 Net Revenue, 2016-2020
      • 10.5.4.2 Segmental Revenue Shares, 2020
    • 10.5.5 Recent Developments, 2017-2020
  • 10.6 ABBVIE
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Service Portfolio
    • 10.6.4 Financial Analysis
      • 10.6.4.1 Net Revenue, 2016-2020
      • 10.6.4.2 Segmental Revenue Shares, 2020
      • 10.6.4.3 Regional Revenue Shares, 2020
    • 10.6.5 Recent Developments, 2020
  • 10.7 SIEGFRIED HOLDING AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Service Portfolio
    • 10.7.4 Financial Analysis
      • 10.7.4.1 Net Revenue, 2016-2020
    • 10.7.5 Recent Developments, 2019
  • 10.8 EVONIK INDUSTRIES
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Service Portfolio
    • 10.8.4 Financial Analysis
      • 10.8.4.1 Net Revenue, 2016-2020
      • 10.8.4.2 Segmental Revenue Shares, 2020
      • 10.8.4.3 Regional Revenue Shares, 2019
    • 10.8.5 Recent Developments, 2020
  • 10.9 BOEHRINGER INGELHEIM
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Service Portfolio
    • 10.9.4 Financial Analysis
      • 10.9.4.1 Net Revenue, 2016-2020
      • 10.9.4.2 Segmental Revenue Shares, 2020
      • 10.9.4.3 Regional Revenue Shares, 2020
    • 10.9.5 Recent Developments, 2017-2019
  • 10.10 PIRAMAL PHARMA SOLUTIONS
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Service Portfolio
    • 10.10.4 Financial Analysis
      • 10.10.4.1 Net Revenue, 2017-2021
      • 10.10.4.2 Segmental Revenue Shares, 2021
      • 10.10.4.3 Regional Revenue Shares, 2021
    • 10.10.5 Recent Developments, 2020
  • 10.11 SAMSUNG BIOLOGICS
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Service Portfolio
    • 10.11.4 Financial Analysis
      • 10.11.4.1 Segmental Revenue Shares, 2020
      • 10.11.4.2 Regional Revenue Shares, 2020
    • 10.11.5 Recent Developments, 2017-2020
  • 10.12 WUXI APPTEC (WUXI STA)
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Service Portfolio
    • 10.12.4 Recent Developments, 2018-2020
  • 10.13 FUJIFILM HEALTHCARE
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Service Portfolio
    • 10.13.4 Financial Analysis
      • 10.13.4.1 Net Revenue, 2016-2019
      • 10.13.4.2 Segmental Revenue Shares, 2019
      • 10.13.4.3 Regional Revenue Shares, 2019
    • 10.13.5 Recent Developments, 2017-2018
  • 10.14 ICON PLC
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Service Portfolio
  • 10.15 ABNOVA CORPORATION
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Service Portfolio
  • 10.16 VETTER PHARMA INTERNATIONAL
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Service Portfolio

11 Conclusion and Recommendations

  • 11.1 Concluding Remarks from Visiongain
  • 11.2 Recommendations for Market Players
  • 11.3 Leading and Fastest Growing Region

List of Tables

  • Table 1 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 2 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 3 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 4 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 6 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 7 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 8 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 9 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 10 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 11 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 12 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 13 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 14 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 15 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 16 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 17 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 18 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 19 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 20 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 21 Global Pharmaceutical Contract Manufacturing Market Forecast For Parenteral/injectable manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 22 Global Pharmaceutical Contract Manufacturing Market Forecast For Tablet manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 23 Global Pharmaceutical Contract Manufacturing Market Forecast For Capsule manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 24 Global Pharmaceutical Contract Manufacturing Market Forecast For Oral liquid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 25 Global Pharmaceutical Contract Manufacturing Market Forecast For Semi-solid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 26 Global Pharmaceutical Contract Manufacturing Market Forecast For Other Formulation manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 27 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 28 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 29 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 30 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug
  • Figure 44. Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 31 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 32 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 33 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 34 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 35 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 36 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 37 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 38 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 39 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 40 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 41 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 42 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 43 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
  • Table 44 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 45 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 46 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 47 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR%)
  • Table 48 Global Pharmaceutical Contract Manufacturing Market Forecast For Big Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 49 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies (PCR), 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 50 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 51 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 52 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 53 Global Pharmaceutical Contract Manufacturing Market Forecast For Small & Medium-Sized Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR%)
  • Table 54 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 55 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 56 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 57 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 58 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 59 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 60 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies (ISH), 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 61 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 62 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 63 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 64 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 65 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 66 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 67 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 68 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
  • Table 69 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 70 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 71 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 72 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 73 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 74 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 75 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 76 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 77 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 78 US Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 79 US Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 80 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 81 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 82 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 83 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 84 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 85 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 86 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 87 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 88 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 89 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 90 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 92 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 93 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 94 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
  • Table 95 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 96 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 97 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 98 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 99 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 100 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 101 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 102 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 103 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 104 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 105 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 106 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 107 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 108 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 109 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 110 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 111 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 112 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 113 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 114 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 115 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 116 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 117 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 118 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 119 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 120 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 121 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 122 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 123 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 124 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 125 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 126 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 127 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 128 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 129 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 130 France Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 131 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 132 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 133 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 134 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 135 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 136 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 137 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 138 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 139 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 140 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 141 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 142 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 143 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 144 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 145 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 146 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 147 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 148 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 149 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 150 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 151 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 152 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 153 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 154 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 155 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 156 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 157 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 158 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 159 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 160 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
  • Table 161 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 162 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 163 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 164 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 165 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 166 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 167 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 168 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 169 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 170 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 171 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 172 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 173 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 174 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 175 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 176 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 177 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 178 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 179 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 180 China Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 181 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 182 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 183 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 184 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 185 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 186 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 187 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 188 India Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 189 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 190 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 191 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 192 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 193 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 194 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 195 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 196 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 197 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 198 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 199 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 200 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 201 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 202 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 203 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 204 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 205 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 206 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 207 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 208 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 209 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 209 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
  • Table 210 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 211 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 212 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 213 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 214 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 215 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 216 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 217 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 218 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 219 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 220 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 221 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 222 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 223 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 224 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 225 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 226 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 227 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 229 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 230 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 231 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 232 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 233 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 234 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 235 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 236 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Service, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 237 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 238 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 239 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 240 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 241 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 242 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 243 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 244 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 245 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 246 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 247 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Table 248 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 249 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 250 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 251 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery

List of Figures

  • Figure 1 Global Pharmaceutical Contract Manufacturing Market Segmentation
  • Figure 2 Global Pharmaceutical Contract Manufacturing Market: Market Trends
  • Figure 3 Global Pharmaceutical Contract manufacturing Market: SWOT Analysis
  • Figure 4 Pharmaceutical Contract Manufacturing Market Porter's Five Forces.
  • Figure 5 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: V-Shaped Recovery
  • Figure 6 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: U-Shaped Recovery
  • Figure 7 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: L-Shaped Recovery
  • Figure 8 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: W-Shaped Recovery
  • Figure 9 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 9. Global Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2021, 2027, 2032 (%)
  • Figure 10. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 11. Global Pharmaceutical Contract Manufacturing Market Share for Pharmaceutical Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 12. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 13. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 14. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 15. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 16. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical API Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 17. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical API Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 18. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 19. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 20. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 21. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 22. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical FDF Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 23. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical FDF Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 24. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 25. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services (USD Billion), 2022-2032: U-Shaped Recovery
  • Figure 26. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 27. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 28. Global Pharmaceutical Contract Manufacturing Market Share For Parenteral/injectable manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 29. Global Pharmaceutical Contract Manufacturing Market Share For Parenteral/injectable manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 30. Global Pharmaceutical Contract Manufacturing Market Share For Tablet manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 31. Global Pharmaceutical Contract Manufacturing Market Share For Tablet manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 32. Global Pharmaceutical Contract Manufacturing Market Share For Capsule manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 33. Global Pharmaceutical Contract Manufacturing Market Share For Capsule manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 34. Global Pharmaceutical Contract Manufacturing Market Share For Oral liquid manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 35. Global Pharmaceutical Contract Manufacturing Market Share For Oral liquid manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 36. Global Pharmaceutical Contract Manufacturing Market Share For Semi-solid manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 37. Global Pharmaceutical Contract Manufacturing Market Share For Semi-solid manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 38. Global Pharmaceutical Contract Manufacturing Market Share For Other Formulation manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 39. Global Pharmaceutical Contract Manufacturing Market Share For Other Formulation manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 40. Global Pharmaceutical Contract Manufacturing Market Share For Drug Development Services, Forecast by Region 2022-2032 (US$ billion, AGR %)
  • Figure 41. Global Pharmaceutical Contract Manufacturing Market Share For Drug Development Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 42. Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 43. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 45. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 46. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 47. Global Pharmaceutical Contract Manufacturing Market Share For Biologics contract manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 48. Global Pharmaceutical Contract Manufacturing Market Share For Biologics contract manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 49. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 50. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 51. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 52. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 53. Global Pharmaceutical Contract Manufacturing Market Share For Biologics API Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 54. Global Pharmaceutical Contract Manufacturing Market Share For Biologics API Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 55. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 56. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 57. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 58. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 59. Global Pharmaceutical Contract Manufacturing Market Share For Biologics FDF Manufacture Service, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 60. Global Pharmaceutical Contract Manufacturing Market Share For Biologics FDF Manufacture Service, Forecast by Region, 2021, 2027, 2032 (%)
  • Figure 61. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 62. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 63. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 64. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 65. Global Pharmaceutical Contract Manufacturing Market, Forecast by End User, 2022-2032 (US$ billion, AGR %)
  • Figure 66.
  • Figure 67. Global Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 68. Global Pharmaceutical Contract Manufacturing Market Share For Big Pharmaceutical Companies, Forecast by Region, 2022-2032 (US$ billion, AGR %)
  • Figure 69. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Big Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
  • Figure 70. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 71. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 72. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 73. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 74. Global Pharmaceutical Contract Manufacturing Market Share For Small & Medium-Sized Pharmaceutical Companies, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 75. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Small & Medium-Sized Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
  • Figure 76. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 77. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 78. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 79. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 80. Global Pharmaceutical Contract Manufacturing Market Share For Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 81. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Generic Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
  • Figure 82. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 83. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies (ISH) 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 84. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 85. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 86. Global Pharmaceutical Contract Manufacturing Market Share For Other End Users by Region, 2021- 2031 (US$ Billion)
  • Figure 87. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Other End Users by Region, 2021, 2027, 2032 (%)
  • Figure 88. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 89. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 90. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 91. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 93 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 94 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 95 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 96 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 97 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 92. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 98 North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2021 and 2032 (%)
  • Figure 93. North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 99 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 94. North America Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 100 North America Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 95. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 101 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 96. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 102 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
  • Figure 97. US Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 103 US Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 104 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 105 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 106 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 107 US Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 108 US Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 109 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 110 US Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 111 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
  • Figure 112 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 113 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 114 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 115 Canada Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 116 Canada Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 117 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 118 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 119 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 120 Canada Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 121 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 122 Canada Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 123 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR %) V-Shaped Recovery
  • Figure 124 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 125 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 126 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 127 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 128 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 129 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 130 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 131 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 132 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Products & Services, 2022-2032 (US$ billion, AGR%, CAGR%)
  • Figure 133 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
  • Figure 134 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 135 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 136 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 137 Europe Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 138 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 139 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 140 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 141 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
  • Figure 142 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 143 Germany Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 144 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 145 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 146 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 147 Germany Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 148 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 149 Germany Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 150 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 151 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 152 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 153 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 154 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 155 UK Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 156 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 157 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 158 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 159 UK Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 160 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 161 UK Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 162 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 163 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 164 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 165 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 166 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 167 Switzerland Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 168 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 169 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 170 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 171 Switzerland Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 172 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 173 Switzerland Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 174 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 175 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 176 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 177 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market (USD Billion, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 178 France Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 179 France Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 180 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 181 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 182 France Biologics Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 183 France Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 184 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 185 France Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 186 COVID-19 Impact on France Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 187 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 188 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 189 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market (USD Billion,2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 190 Italy Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 191 Italy Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 192 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 193 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 194 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 195 Italy Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 196 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 197 Italy Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 198 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 200 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 201 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 202 Spain Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 203 Spain Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 204 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 205 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 206 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 207 Spain Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 208 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 209 Spain Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 210 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 211 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 212 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 213 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 214 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 215 Rest of Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 216 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 217 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 218 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 219 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 220 Rest of Europe Biologics Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 221 Rest of Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 222 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 223 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 224 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 225 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 226 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 227 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2019-2031: V-Shaped Recovery
  • Figure 228 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: U-Shaped Recovery
  • Figure 229 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: L-Shaped Recovery
  • Figure 230 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: W-Shaped Recovery
  • Figure 98. Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 231 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
  • Figure 99. Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 232 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 233 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 234 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 235 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 236 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 237 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 238 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
  • Figure 239 Japan Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 240 Japan Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 241 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 242 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 243 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 244 Japan Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 245 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 246 Japan Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 247 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 248 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 249 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 250 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%)W-Shaped Recovery
  • Figure 251 China Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 252 China Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 253 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 254 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 255 China Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 256 China Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 257 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 258 China Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 259 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 260 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 261 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 262 COVID-19 Impact on China Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 263 India Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 264 India Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 265 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 266 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 267 India Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 268 India Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 269 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 270 India Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 271 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 272 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 273 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market, 2022-2032 (US$ billion, AGR%, CAGR%) 2022-2032: L-Shaped Recovery
  • Figure 274 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 275 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 276 South Korea Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 277 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 278 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 279 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 280 South Korea Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 281 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 282 South Korea Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 283 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 284 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 286 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 287 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 288 Rest of APAC Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 289 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 290 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 291 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 292 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 293 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 294 Rest of APAC Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 295 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 296 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 297 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 298 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 299 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 300 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 301 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 302 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 303 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 304 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 305 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
  • Figure 306 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 307 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 308 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 309 LAMEA Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 310 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 311 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 312 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 313 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
  • Figure 314 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 315 Brazil Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 316 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 317 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 318 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 319 Brazil Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 320 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 321 Brazil Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 322 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 323 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR %) U-Shaped Recovery
  • Figure 324 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 325 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 326 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 327 Mexico Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 328 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 329 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 330 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 331 Mexico Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 332 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 333 Mexico Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 334 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 335 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 336 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 337 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 338 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Services, 2021- 2031 (US$ Billion)
  • Figure 339 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 340 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021- 2031 (US$ Billion)
  • Figure 341 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 342 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2021- 2032 (US$ Billion)
  • Figure 343 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 344 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User,, 2021- 2032 (US$ Billion)
  • Figure 345 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 346 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market (USD Billion), 2019-2031: V-Shaped Recovery
  • Figure 347 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 348 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 349 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 350 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 351 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
  • Figure 352 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 353 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 354 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 355 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
  • Figure 356 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
  • Figure 357 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
  • Figure 358 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
  • Figure 359 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
  • Figure 360 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
  • Figure 361 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
  • Figure 363 Lonza: Net Revenue, 2016-2020 (US$ Million, AGR%)
  • Figure 364 Lonza: Segmental Revenue Shares 2020
  • Figure 365 Lonza: Regional Revenue Shares 2020
  • Figure 366 THERMO FISHER SCIENTIFIC: Net Revenue, 2017-2020 (US$ Million, AGR %)
  • Figure 367 THERMO FISHER SCIENTIFIC: Segmental Revenue Shares 2020
  • Figure 368 Thermo Fisher Scientific: Regional Revenue Shares 2020
  • Figure 369 CATALENT: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 370 CATALENT: Segmental Revenue Shares 2021
  • Figure 371 CATALENT: Regional Revenue Shares 2021
  • Figure 372 RECIPHARM AB: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 373 RECIPHARM AB: Segmental Revenue Shares 2020
  • Figure 374 ABBVIE: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 375 ABBVIE: Segmental Revenue Shares 2020
  • Figure 376 ABBVIE: Regional Revenue Shares 2020
  • Figure 377 SIEGFRIED: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 378 Evonik: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 379 Evonik: Segmental Revenue Shares 2020
  • Figure 380 Evonik: Regional Revenue Shares 2019
  • Figure 381 Boehringer Ingelheim: Net Revenue, 2016-2020 (US$ Million, AGR %)
  • Figure 382 Boehringer Ingelheim: Segmental Revenue Shares 2020
  • Figure 383 Boehringer Ingelheim: Regional Revenue Shares 2020
  • Figure 384 Piramal Enterprises: Net Revenue, 2017-2021 (US$ Million, AGR %)
  • Figure 385 Primal Enterprises: Segmental Revenue Shares 2021
  • Figure 386 Primal Enterprises: Regional Revenue Shares 2021
  • Figure 387 Samsung Biologics: Segmental Revenue Shares 2020
  • Figure 388 Samsung Biologics: Regional Revenue Shares 2020
  • Figure 389 Fujifilm: Net Revenue, 2016-2019 (US$ Million, AGR %)
  • Figure 390 Fujifilm: Segmental Revenue Shares 2019
  • Figure 391 Fujifilm: Regional Revenue Shares 2019
  • Figure 392 Pharmaceutical Contract Manufacturing Market Share Forecast, by Region, 2021, 2027 and 2032 (%)

Companies Profiled in the Report:

  • AbbVie Inc.
  • Abnova Corporation
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Evonik Industries AG
  • Fujifilm Corporation
  • ICON PLC
  • Lonza Group Ltd.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma International GmbH
  • WuXiAppTec

List of Other Companies:

  • Actavis
  • ADC Biotechnology
  • Aegerion Pharmaceuticals
  • Aesica Pharma
  • Alexion Pharmaceuticals
  • Astellas
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Daito Pharmaceutical
  • Delpharm
  • DPx Holdings B.V.
  • Dr. Reddy's Laboratories
  • Eisai
  • Eli Lilly
  • G-CON
  • Gallus Biopharmaceutical, LLC.
  • GlaxoSmithKline (GSK)
  • Indian Pharmaceutical Alliance
  • Innovent Biologics
  • IRIX Pharmaceuticals
  • Janssen
  • JK Pharmaceutical
  • Johnson & Johnson
  • Lupin
  • Marinopoulos Group
  • Matrix Laboratories
  • Medice
  • Medichem
  • Merck & Co.
  • Mylan
  • Neuland Laboratories
  • Orchid Chemicals & Pharmaceuticals
  • Oxford Biomedica
  • Progenics
  • Recepta Biopharma
  • Roche
  • Shire
  • SMS Pharmaceuticals
  • Takeda
  • Valeant Pharmaceuticals
  • West Pharmaceutical Services

List of Organizations:

  • Association of British Pharmaceutical Industry (ABPI)
  • Central Drugs Standard Control Organization (CDSCO)
  • Department of Health and Family Welfare
  • Development and Reform Commission (NDRC)
  • European Commission
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • Indian Drug Manufacturer's Association (IDMA)
  • International Society of Pharmaceutical Engineering (IPSE)
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Manufacturing Industry Partnership (MMIP)
  • Ministry of Health (MOH)
  • Ministry of Health, Labor and Welfare (MHLW)
  • Ministry of Industry and Information Technology (MIIT)
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • World Health Organization (WHO)